Nephrocare Health Services Schedules Q4FY26 Earnings Conference Call for May 20, 2026
Nephrocare Health Services has scheduled its Q4FY26 Results Conference Call for May 20, 2026, at 16:00 IST, hosted by ICICI Securities. Senior leadership including the CMD, Co-Founder, Group CEO, and Group CFO will represent the company. The call will cover audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, with discussions limited to publicly available information.
*this image is generated using AI for illustrative purposes only.
Nephrocare Health Services Limited has announced the scheduling of its Q4FY26 Results Conference Call, pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The call is set to take place on Wednesday, May 20, 2026, at 16:00 IST, and will focus on the company's audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The intimation was filed with BSE Limited and the National Stock Exchange of India Limited on May 04, 2026.
Event Details
The conference call will be hosted by ICICI Securities and will feature key members of Nephrocare Health Services' senior leadership. The following table summarises the scheduled event:
| Parameter: | Details |
|---|---|
| Event: | Q4FY26 Results Conference Call |
| Date: | Wednesday, May 20, 2026 |
| Time: | 16:00 IST |
| Hosted by: | ICICI Securities |
| Regulatory Reference: | Regulation 30, SEBI Listing Regulations |
Senior Leadership Representing the Company
The following senior officials of Nephrocare Health Services will represent the company during the call:
- Mr. Vikram Vuppala — Chairman & Managing Director
- Mr. Kamal Shah — Co-Founder
- Mr. Rohit Singh — Group Chief Executive Officer
- Mr. Prashant Goenka — Group Chief Financial Officer
Access Details
Participants may join the call through the following dial-in numbers:
| Region: | Number |
|---|---|
| Universal Access (India): | +91 22 6280 1144; +91 22 7115 8045 |
| Singapore (Toll Free): | 8001012045 |
| Hong Kong (Toll Free): | 800964448 |
| UK (Toll Free): | 08081011573 |
| USA (Toll Free): | 18667462133 |
Disclosure and Compliance
The company has clarified that all discussions during the call will be based on publicly available information, and no unpublished price sensitive information (UPSI) is intended to be discussed. The disclosure has been made available on the company's official website at www.nephroplus.com . The intimation was signed by Kishore Kathri, Company Secretary & Compliance Officer (ICSI M. No. F9895), on behalf of Nephrocare Health Services Limited.
Historical Stock Returns for Nephrocare Health Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.01% | +2.97% | +2.84% | +15.64% | +15.64% | +15.64% |
How has Nephrocare Health Services' revenue and EBITDA margin trended over FY26 compared to previous years, and what guidance might management provide for FY27?
Given the inclusion of both standalone and consolidated results, what acquisitions or subsidiary expansions has Nephrocare undertaken that could significantly impact its consolidated financials?
With dialysis services being highly capital-intensive, how is Nephrocare planning to fund its network expansion, and what is its current debt-to-equity position heading into FY27?
17
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
